Risk of development of more-advanced lesions in patients with inflammatory bowel diseases and dysplasia

Autor: Cremer, Anneline, Demetter, Pieter, De Vos, Martine, Rahier, Jean-François, Baert, Filip, Moreels, Tom, Macken, Elisabeth, Louis, Edouard, Ferdinande, Liesbeth, Fervaille, Caroline, Dedeurwaerdere, Franceska, Bletard, Noela, Driessen, Ann, De Hertogh, Gert, Vermeire, Séverine, Franchimont, Denis, Belgian Inflammatory Bowel Disease Research and Development (BIRD) Group

Publikováno v: Clinical gastroenterology and hepatology
Clinical gastroenterology and hepatology, Vol. 18, no. 7, p. 1528-1536.e5 (2020)

Patients with inflammatory bowel diseases (IBD) have increased risks of dysplasia and colitis-associated cancer (CAC). We evaluated the risk of development of high-grade dysplasia (HGD) or CAC after diagnosis of dysplasia using data from a national c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6d2b9fe144bdc89a3f073f190875b8
https://hdl.handle.net/10067/1713020151162165141

The Dynamics of Nucleotide Variants in the Progression from Low-Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach.

Autor: Oben B; Laboratory Experimental Hematology, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium.; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium., Cosemans C; Laboratory Experimental Hematology, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium.; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; Centre for Environmental Sciences, Hasselt University, 3590 Diepenbeek, Belgium., Geerdens E; Laboratory Molecular Diagnostics, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium., Linsen L; Laboratory Experimental Hematology, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium.; Activity Center Biobanking, University Hospitals Leuven, 3000 Leuven, Belgium.; University Biobank Limburg (UBiLim), Clinical Biobank, Jessa Hospital, 3500 Hasselt, Belgium., Vanhees K; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; University Biobank Limburg (UBiLim), Clinical Biobank, Jessa Hospital, 3500 Hasselt, Belgium., Maes B; Laboratory Molecular Diagnostics, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium., Theunissen K; Department Hematology, Jessa Hospital, 3500 Hasselt, Belgium., Cruys B; Laboratory Molecular Diagnostics, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium., Lionetti M; Department Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Arijs I; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; Laboratory for Translational Genetics, Department Human Genetics, University of Leuven, 3000 Leuven, Belgium.; Belgian Inflammatory Bowel Disease Research and Development (BIRD), 1930 Zaventem, Belgium., Bolli N; Department Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.; Unità Operativa Complessa di Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy., Froyen G; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; Laboratory Molecular Diagnostics, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium., Rummens JL; Laboratory Experimental Hematology, Department Clinical Biology, Jessa Hospital, 3500 Hasselt, Belgium.; Faculty of Medicine and Life Sciences, Hasselt University, 3500 Hasselt, Belgium.; University Biobank Limburg (UBiLim), Clinical Biobank, Jessa Hospital, 3500 Hasselt, Belgium.

Publikováno v: Cancers [Cancers (Basel)] 2022 Feb 18; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 18.